POLYCYTHEMIA VERA
POLYCYTHEMIA VERA
A
myeloproliferative disorder that results in an overproduction of blood cells
and a thickening of blood. The hallmarks of polycythemia vera include excessive
production of red blood cells, white blood cells, and platelets. The excess of
cells present in the blood causes problems with the flow of blood through
vessels, especially the smaller ones. There will be an increase in peripheral
vascular resistance causing increased pressure, and vascular stasis in the smaller
vessels, potentially causing thrombosis or tissue hypoxia. Organ damage may
result because of these changes.
PROGNOSIS
After
diagnosis of polycythemia vera, the average survival time is 10 to 15 years with
appropriate treatment, less than 2 years without treatment. Some patients may go
on to develop acute leukemia. Complications usually arise from thrombosis or tissue
hypoxia.
SIGNS
AND SYMPTOMS
•
Facial skin and mucous membranes dark and flushed (plethora)
•
Hypertension due to increased peripheral vascular resistance and thickening of
the blood
•
Itching worse after warm shower due to histamine release from increased basophils
within dilated vessels
•
Headache and difficulty concentrating
•
Vision blurred, tinnitus (ringing in ears), and hearing changes
•
Thrombosis due to vascular stasis
•
Spleen enlargement (splenomegaly)
•
Tissue hypoxia and possible infarction of heart, spleen, kidneys, and brain due
to thrombosis
INTERPRETING
TEST RESULTS
•
Increased RBC count.
•
Increased hemoglobin.
•
Increased hematocrit level.
•
Increased WBC count.
•
Increased basophils.
•
Increased eosinophils.
•
Increased platelet count.
•
Increased uric acid level.
•
Increased potassium.
•
Increased vitamin B12 level.
•
Bone marrow panhyperplasia; iron stores absent.
TREATMENT
Treatment
is aimed at maintaining blood flow to the smaller vessels and diminishing the
amount of excess blood cells being made by the bone marrow.
•
Periodic scheduled phlebotomy—the removal of 500 ml of blood—to reduce the
hematocrit level to below 45; may be done weekly. • Adequate hydration.
•
Anticoagulants such as aspirin.
•
Administer myelosuppressive medication:
•
Hydroxyurea
•
Anagrelide
•
Radioactive phosphorus 32
•
Administer medication to lower uric acid level if necessary:
•
Allopurinol
•
Alkylating agents:
•
Melphalan
•
Busulfan
•
Radiation therapy.
•
Antihistamine for pruritis.
NURSING
DIAGNOSES
•
Ineffective tissue perfusion
•
Disturbed sensory perception
•
Risk for injury
NURSING
INTERVENTION
•
Monitor vital signs.
•
Monitor for bleeding.
•
Monitor for signs of infections.
•
Keep the patient mobilized to decrease chance of clot formation.
•
Increase fluid intake.
•
Explain to the patient:
•
Maintain activity.
•
Use electric razor, use soft toothbrush, and avoid flossing to decrease chances
of bleeding.
•
Avoid activities that could cause injury.
Comments
Post a Comment